Please use this identifier to cite or link to this item:
Title: Rare Case of Hepatic Gaucheroma in a Child on Enzyme Replacement Therapy
Authors: Owens, Penny ;Korula, S.;Charlton, A.;Bhattacharya, K.
Affliation: Central Coast Local Health District
Gosford Hospital
Issue Date: Jun-2016
Source: 32:101-104
Journal title: JIMD Reports
Department: Diabetes, Endocrinology & Metabolism
Abstract: BACKGROUND: We present a 6 year old boy with type I Gaucher treated from 16 months with ERT, developing focal Gaucheroma in the liver at 3.5 years. CASE: The subject presented at 13 months of age with anaemia, thrombocytopenia and hepatosplenomegaly. Gaucher disease was confirmed by leucocyte enzyme assay. A homozygous change: c.1193G>A (p.Arg398Gln) in the GBA gene was identified. He had normal neurology with normal saccades. Imiglucerase was administered at 60 IU/kg/fortnight from 15 months as per Australian regulations with good clinical response. At 3.5 years hepatic ultrasound demonstrated a nodular cystic lesion measuring 7 × 5.3 × 5.1 cm in the right lobe of liver, confirmed on MRI. Biopsy demonstrated acellular hyaline necrosis, portal-portal bridging fibrosis and nodules of Gaucher cells. Cystic fluid comprised necrotic debris and Gaucher cells. Further evaluation over 18 months including repeat MRI, biopsy, alpha-fetoprotein monitoring and whole-body FDG-Pet scan demonstrate no malignancy. CONCLUSION: GD is the most common lysosomal storage disorder. The aetiology, natural history and optimal management strategy of rare Gaucheroma in paediatric cases has not been defined particularly in regards to malignancy risk.
DOI: 10.1007/8904_2016_562
ISSN: 2192-8304
Publicaton type: Journal Article
Keywords: Child
Study or Trial: Case Series and Case Reports
Appears in Collections:Obstetrics / Paediatrics

Show full item record

Page view(s)

checked on Jun 3, 2023

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.